• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    More On IPCI


    IntelliPharmaCeutics International Inc. (IPCI)

    -NasdaqCM
    2.40 Down 0.06(2.44%) 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingNov 30, 2013Nov 30, 2012Nov 30, 2011
    Total Revenue 1,527   107   502  
    Cost of Revenue -   -   -  
    Gross Profit 1,527   107   502  
    Operating Expenses
    Research Development5,076  5,992  5,126  
    Selling General and Administrative2,873  3,672  2,925  
    Non Recurring -  107   -  
    Others397  452  227  
    Total Operating Expenses -  10,224   -  
    Operating Income or Loss (6,819) (10,117) (7,777)
    Income from Continuing Operations
    Total Other Income/Expenses Net(4,246)4,044  5,338  
    Earnings Before Interest And Taxes(11,065)(6,073)(2,439)
    Interest Expense430  63  2,441  
    Income Before Tax(11,495)(6,137)(4,880)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(11,495)(6,137)(4,880)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (11,495) (6,137) (4,880)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (11,495) (6,137) (4,880)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.